| Bioactivity | RNAENFDRF (βIIPKC624-632) TFA is conjugated to the cell permeable peptide TAT47-57, which can be used to form an inhibitory peptide SAMβA. SAMβA, a rationally designed selective antagonist of Mfn1-βIIPKC association. SAMβA is a selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats[1]. | ||||||
| Name | RNAENFDRF TFA | ||||||
| Sequence | Arg-Asn-Ala-Glu-Asn-Phe-Asp-Arg-Phe | ||||||
| Shortening | RNAENFDRF | ||||||
| Formula | C52H74F3N17O18 | ||||||
| Molar Mass | 1282.24 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
RNAENFDRF TFA
CAS: F: C52H74F3N17O18 W: 1282.24
RNAENFDRF (βIIPKC624-632) TFA is conjugated to the cell permeable peptide TAT47-57, which can be used to form an inhibi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.